Capricor Therapeutics (CAPR) Interest Coverage Ratio (2013 - 2026)

Capricor Therapeutics' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 59.82 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 45.59% year-over-year to 59.82 in Q1 2026; TTM through Mar 2026 was 35.09, a 57.67% increase from a year earlier, with the FY2025 full-year figure at 0.39, up 7.03% from the prior year.
• Interest Coverage Ratio fell to 59.82 in Q1 2026 per CAPR's latest filing, from 12.41 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 26.37 in Q4 2022 and bottomed at 254.82 in Q1 2023.
• The 5-year median for Interest Coverage Ratio is 1.67 (2022), against an average of 32.34.
• Across the five-year window, Interest Coverage Ratio jumped 99.87% in 2024 and tumbled 33136.24% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 26.37 in 2022, then slumped by 123.69% to 6.25 in 2023, then tumbled by 443.34% to 33.95 in 2024, then surged by 63.45% to 12.41 in 2025, then plunged by 382.04% to 59.82 in 2026.
• Per Business Quant, the three latest CAPR Interest Coverage Ratio figures stand at 59.82 (Q1 2026), 12.41 (Q4 2025), and 0.79 (Q3 2025).